Chargement en cours...
Durvalumab-Induced Diffuse Alveolar Hemorrhage: An Autopsy Case Report
Durvalumab, a programmed cell death ligand 1 inhibitor, induces various immune-related adverse events (irAEs), including lung injury. However, diffuse alveolar hemorrhage (DAH) is a rare type of lung injury due to immune checkpoint inhibitors. A 76-year-old man with c-stage IIIA squamous cell carcin...
Enregistré dans:
| Publié dans: | Case Rep Oncol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger AG
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7383190/ https://ncbi.nlm.nih.gov/pubmed/32774259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507848 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|